The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study

被引：4
|
作者：
Workman, Craig D. [1 ]
Kindred, John H. [2 ]
Ponto, Laura L. Boles [3 ]
Kamholz, John [4 ]
Rudroff, Thorsten [1 ,4 ]
机构：
[1] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA
[2] Med Univ South Carolina, Dept Phys Therapy, Charleston, SC 29425 USA
[3] Univ Iowa Hlth Clin, Dept Radiol, Iowa City, IA 52242 USA
[4] Univ Iowa Hlth Clin, Dept Neurol, Iowa City, IA 52242 USA
来源：
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM | 2020年 / 45卷 / 04期
关键词：
multiple sclerosis; PET scan; cannabis; THC; CBD; chronic effects; MARIJUANA; PEOPLE; TRIAL;
D O I：
10.1139/apnm-2019-0634
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
This exploratory pilot study investigated the effects of chronic Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on cerebral glucose metabolism in people with multiple sclerosis (PwMS). Compared with nonusers, THC users had hypermetabolism of 3 regions (p < 0.039, d >1.17) in left temporal areas, while CBD users had hypometabolism of 5 regions (p < 0.032, d > 1.31) in left temporal areas. This study highlights the need to discriminate between THC and CBD in future cannabis studies. Novelty Chronic THC and CBD use had disparate effects on cerebral glucose metabolism in PWMS.
引用
收藏
页码：450 / 452
页数：3
相关论文
共 50 条
  • [21] Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
    Antonio Waldo Zuardi
    Jaime Eduardo Cecílio Hallak
    José Alexandre S. Crippa
    Psychopharmacology, 2012, 219 : 247 - 249
  • [22] Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
    Clarke, Stephen
    Butcher, Belinda E.
    McLachlan, Andrew J.
    Henson, Jeremy D.
    Rutolo, David
    Hall, Sean
    Vitetta, Luis
    PLOS ONE, 2022, 17 (10):
  • [23] Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration
    Sholler, Dennis J.
    Spindle, Tory R.
    Cone, Edward J.
    Goffi, Elia
    Kuntz, David
    Mitchell, John M.
    Winecker, Ruth E.
    Bigelow, George E.
    Flegel, Ronald R.
    Vandrey, Ryan
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2021, 46 (05) : 494 - 503
  • [24] Effects of daily?9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates
    Withey, Sarah L.
    Kangas, Brian D.
    Charles, Sophia
    Gumbert, Andrew B.
    Eisold, Jessica E.
    George, Susan R.
    Bergman, Jack
    Madras, Bertha K.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 221
  • [25] Combination of cannabinoids, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigate experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
    Al-Ghezi, Zinah Zamil
    Alghetaa, Hasan F.
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [26] Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC–MS/MS detection
    Roberta Gorziza
    Joseph Cox
    Renata Pereira Limberger
    Luis E. Arroyo-Mora
    Journal of Cannabis Research, 3
  • [27] In smoked cannabis, cannabidiol attenuates the acute memory impairing effects of delta 9-tetrahydrocannabinol (THC)
    Curran, V.
    Schafer, G.
    Freeman, T.
    Morgan, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 48 - 48
  • [28] IN SMOKED CANNABIS, CANNABIDIOL ATTENUATES THE ACUTE MEMORY IMPAIRING EFFECTS OF DELTA 9-TETRAHYDROCANNABINOL (THC)
    Freeman, T. P.
    Morgan, C. J. A.
    Schafer, G. L.
    Curran, H., V
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A61 - A61
  • [29] Effects of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC:CBD mixtures on the physiological and behavioral signs of opioid withdrawal in rhesus monkeys
    Carey, Lawrence
    France, Charles
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1091 - 1091
  • [30] Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations
    Moore, Catherine F.
    Weerts, Elise M.
    PSYCHOPHARMACOLOGY, 2022, 239 (05) : 1397 - 1408
12345